Article
AI-driven selection of patients with non-valvular atrial fibrillation for oral anticoagulation therapy: a multi-cohort validation and impact evaluation study
2026-03-25
Abstract excerpt
<h4>Background</h4> Current risk assessment tools for guiding direct oral anticoagulant (DOAC) therapy for patients with atrial fibrillation (AF) based on clinical risk factors demonstrate modest predictive performance limiting clinical impact. Additionally, while guidelines recommend periodic reassessment of risk over time, there remains an absence of modelling solutions for capturing evolving risk in AF patient...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 179d476d-6883-57ee-82cd-9bc05d68a125
- DOI
- 10.64898/2026.03.23.26349067
